Trovafloxacin Mesylate

甲磺酸曲伐沙星

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTrovafloxacin Mesylate
Drug Alias Name甲磺酸曲氟沙星trovafloxacine甲黄酸曲氟沙星Trovafloxacin mesilatetrovafloxacinum +[10] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsBacterial InfectionsInfections
Global Approved IndicationsBacterial InfectionsInfections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1997/12/18
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer LtdPfizer Inc
Active IndicationsN/A
Inactive IndicationsBacterial InfectionsInfections

Other Information

ATC CodeJ01MA13
Related LinksWikipediaDrugBankKEGG